Funding
CPMS ID 45782]
REVISE is funded by peer-reviewed grants [Canadian Institutes of Health Research 201610PJT-378226-PJT-CEBA-18373; Canadian Institutes of Health Research 202207CL3-492565-CTP-CEBA-19215]. The National Health and Medical Research Council of Australia grant [GNT1124675] funds enrolment in Australia. REVISE was approved by the National Institute for Health Research (NIHR) in the UK as a Portfolio Study [CPMS ID 45782], eligible for support from the NIHR Clinical Research Network. [